News and Conferences
1
-
Society for Neuroscience 2024
Read moreWe will be attending and exhibiting at SfN 2024 in Chicago, our biggest conference of the year. Excitingly, we will be presenting FIVE posters! Make sure you visit us at Booth #872 to speak to our scientists who are attending. We look forward to seeing you there! Click to see more information on the posters being presented... -
ILAE - 15th European Epilepsy congress
Read moreHead of Neuropharmacology, Pabitra H. Patra and Senior Business Development Manager, Denvor Oorloff, attended ILAE between 7th-11th September in Rome. This was a great opportunity for us to build our relationships with current clients as well as utilizing the conference to build new relationships. -
Kansas City Animal Health Corridor
Read moreAttended between 26th-27th August 2024, the Kansas City Animal Health Corridor was an excellent opportunity to showcase our Animal Health capabilities at a conference we attend yearly. -
IASP 2024 World Congress on Pain
Read moreHead of Neuropharmacology, Pabitra H. Patra and Senior Business Development Manager, Denvor Oorloff attended IASP 2024 World Congress on Pain in Amsterdam, Netherlands between 5th-9th August -
AAIC 2024
Read moreChief Corporate Development Officer, Joseph Araujo & Senior Business Development Officer, Shalini Kot attended AAIC 2024 in Philadelphia, PA from 28th July - 1st August -
OARSI 2024
Read moreHosted in Vienna, Austria between April 18th-21st -
Western Veterinary Conference
Read moreLas Vegas, USA -
AD/PD 2024
Read moreLisbon, Portugal -
Animal Health, Nutrition & Technology Innovation
Read moreLondon, UK -
VMX 2024
Read moreOrlando, Florida
1
Want to see our latest study results?
Sign up for our newsletter.
Newsletters
- Take your R&D pipeline into the AI era with Moseq (Motion Sequencing), our new behavioural machine-learning assay! 2024-08-22
- Canine Microbiome 2024-07-23
- Oral Health: Not just for Humans 2024-06-20
- Novel Object Recognition: A Reliable Assay for Addressing Cognitive Impairments in Schizophrenia 2024-06-11
- Pre-pulse Inhibition: A Promising Screening Tool for Novel Compounds 2024-05-16
- Natural and induced models of osteoarthritis in Beagle dogs 2024-04-30
- Utilizing Rapid Screening Tests to Assess the Antidepressant Potential of Psychedelic Analogues 2024-04-16
- Long-term antidepressant effect of ketamine and psilocybin in the Chronic Social Defeat stress model 2024-03-21
- Diabetes and Metabolic Syndrome 2024-03-14
- Transpharmation's Animal Health Services 2024-02-29
- Longevity Research Goes to the Dogs 2024-02-20
- Transpharmation's Cutting-Edge Antiepileptic Drug Screening: A Global Solution for Advancing Epilepsy Research 2024-02-01
- PTZ-treated Zebrafish provide a high throughput platform for screening novel anti-epileptic drugs 2024-01-25
- Beyond Seizures: Epilepsy Comorbidities Explored in Mouse Kindling Studies 2024-01-18
- Novelty-suppressed feeding and novelty-induced hypophagia: exploring sex differences and response to diazepam in C57BL/6J mice. 2023-12-14
- Development & validation of intrathecal dosing in rats and mice 2023-12-05
- Transpharmation's Mouse-EEG capability reveals cross-species effects of novel antidepressants ketamine and psilocybin 2023-11-22
- Oral Health: Not just for Humans... 2023-10-31
- Accelerate Your Diabetes Drug Development with Transpharmation's Dog Diabetes Models 2023-10-18
- Introducing our new data analysis service for tremor-plate signals! 2023-09-29
- Introducing the Scn1a mutant mouse model of Dravet Syndrome at Transpharmation 2023-09-21
- New validated pre-clinical model to assess treatments for post-surgical pain 2023-08-31
- Experimental Autoimmune Encephalomyelitis; Modelling Multiple Sclerosis and Beyond 2023-08-21
- New Preclinical Models of Migraine for Assessment of Rescue and Preventive Analgesic Treatments 2023-08-01
- Do Your Compounds Exhibit Anti-Inflammatory Compounds 2023-07-17
- Profile your anti-inflammatory compounds in primary human immune cells 2023-06-28
- New EEG services from Transpharmation. Read on for results... 2023-06-14
- Accelerate your Drug Discovery Research. Proven results, fast and cost effective 2023-06-07
- Urgent Treatments Needed for Parkinson's Disease 2023-05-16
- Poor bioavailability, is the liver or intestine to blame? 2023-05-03
- Laser Doppler; new validated protocols revealed. 2023-04-21
- Epilepsy models leading the way. Read on for results. 2023-03-27
- Profiling anti-inflammatory drugs; from rodent to human 2023-03-02
- The Mismatch Negativity Challenge 2023-01-25
- Accelerate your drug discovery research. Proven science based results cost-effectively. 2022-12-20
- Anxiety. Three preclinical tests; data revealed... 2022-12-12
- Seven new posters, presented at SfN, now available to view. 2022-11-23
- Name change announcement! News from the CEO. 2022-11-04
- Chronic fatigue: different etiologies influence translational models 2022-10-18
- Seven new translational studies to share with you at this year's SfN event. Read on for poster titles and contact details. 2022-10-03
- Translational value increased with non-evoked pain measures. 2022-09-21
- Rapid access to PK non-rodent studies. Leading expertise. 2022-09-01
- Essential tremor research 2022-08-19
- Can a psychedelic experience be modelled in rats? 2022-08-01
- Gender Differences in Pain. New research revealed! 2022-06-30
- New data on the effect of single dose psilocybin! 2022-05-25
- From ketamine to psychedelics, join our webinar starting tomorrow! 2022-05-09
- Long term delayed effects of psychedelics in preclinical models. Trailblazing results revealed! 2022-04-05
- Accreditation awarded with flying colours 2022-03-01
- Breaking news! Merger announcement between Transpharmation and InterVivo Solutions. 2022-02-08
- Take a look! New posters, nine therapeutic areas available to view now. 2021-12-01
- Nine new compelling studies to be revealed at SfN21! 2021-11-03
- Can changes in EEG improve neuropathic pain treatments? 2021-10-11
- 40Hz ASSR: sounds that change our thoughts about schizophrenia 2021-08-31
- Clerkenwell Health and Transpharmation combine lab and human trials for psilocybin 2021-08-09
- Translational endpoints for preclinical pain - improving your chances. 2021-07-01
- Transpharmation aims for global standard. Let's talk about lab sustainability. 2021-06-02
- Targeting the unmet medical need in Parkinson's Disease - the fastest growing neurological disorder. 2021-04-15
- Psilocybin: the power of mental reorganisation 2020-12-06
- Expansion to world class premises 2020-11-04
- Multiple therapeutic indications 2020-10-05
- Focus on pain 2020-09-04
- Gene therapies for body and brain in Duchenne Muscular Dystrophy, progress moves forward. 2020-03-08
- Announcing Transpharmation Poland! 2020-02-08